Literature DB >> 5579463

Plasma concentration, uptake by liver, and biliary excretion of tritiated cardiac glycosides in the isolated perfused guinea-pig liver.

K D Kolenda, H Lüllmann, T Peters, K U Seiler.   

Abstract

1. Investigations were carried out on isolated perfused guinea-pig livers. Different doses of tritiated ouabain, digoxin, and digitoxin were added to the perfusion medium and the subsequent plasma elimination, hepatic uptake, and biliary excretion quantitatively measured. After the perfusion, extracts of liver, bile and plasma were subjected to thin layer chromatography in order to detect the radioactively labelled glycosides and their metabolites.2. The ouabain concentration in the plasma approached the equilibrium stage within 45 minutes. At this time 40% of the administered dose had been taken up by the liver, and no further elimination occurred. The elimination curve for ouabain followed a simple exponential function. After 1 h the tissue medium (T/M) ratio was approximately 3. In bile hardly any radioactivity could be detected. Ouabain was therefore not excreted by the liver.3. Up to 80% of the digitoxin was eliminated from the plasma within 4 hours. The elimination of radioactive material for the dose range studied could be described by a hyperbolic function. The T/M ratio in the liver varied with time. At the beginning it was as high as 10 and after 4 h reduced to approximately 3. After 45-60 min the concentration of radioactive material in the bile was 500 times as high as that in the plasma. Almost 70% of the administered radioactivity was excreted with the bile within 4 hours. At the end of the perfusion almost all the identifiable substances in plasma and bile were polar metabolites, as shown by thin layer radiochromatography.4. Digoxin behaved similarly to digitoxin.5. The findings led to the following hypothesis: uptake of cardiac glycosides into the liver cells occurs by a passive diffusion process and is related to their lipid solubility. On the other hand excretion in the bile occurs in general if polar metabolites are formed in the liver cells.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5579463      PMCID: PMC1702773          DOI: 10.1111/j.1476-5381.1971.tb07073.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  The uptake and binding of six radiolabeled cardiac glycosides by guinea-pig hearts and by isolated sarcoplasmic reticulum.

Authors:  S Dutta; S Goswami; D K Datta; J O Lindower; B H Marks
Journal:  J Pharmacol Exp Ther       Date:  1968-11       Impact factor: 4.030

2.  [On the cause of species differences in digitalis sensitivity].

Authors:  K Repke; M Est; H J Portius
Journal:  Biochem Pharmacol       Date:  1965-12       Impact factor: 5.858

Review 3.  The kinetic behaviour of cardiac glycosides in vivo, measured by isotope techniques.

Authors:  H Lüllmann; P A van Zwieten
Journal:  J Pharm Pharmacol       Date:  1969-01       Impact factor: 3.765

Review 4.  The clinical pharmacology of digitalis glycosides: a review.

Authors:  J E Doherty
Journal:  Am J Med Sci       Date:  1968-06       Impact factor: 2.378

5.  Biliary secretion of ouabain-3H and its uptake by liver slices in the rat.

Authors:  H J Kupferberg; L S Schankl
Journal:  Am J Physiol       Date:  1968-05

6.  [Technics of isolated liver perfusion in guinea pigs].

Authors:  J W Berg; K D Kolenda; T Peters; K U Seiler
Journal:  Arztl Forsch       Date:  1970-08-10

7.  [On the pharmacokinetics of peruvoside. II. Comparative studies with H3-ouabain and H3-digitoxin in guinea pigs].

Authors:  A Garbe; H Nowak
Journal:  Arzneimittelforschung       Date:  1968-12

8.  The distribution of 3H-labelled cardenolides between isolated guinea-pig atrial tissue and circulating, oxygenated whole blood.

Authors:  H Lüllmann; T Peters; P A van Zwieten
Journal:  Br J Pharmacol       Date:  1969-06       Impact factor: 8.739

9.  A comparison of the accumulation and release of 3H-ouabain and 3H-digitoxin by guinea-pig heart muscle.

Authors:  K Kuschinsky; H Lüllmann; P A van Zwieten
Journal:  Br J Pharmacol Chemother       Date:  1968-03

10.  Metabolism of cardiac glycosides studied in the isolated perfused guinea-pig liver.

Authors:  K D Kolenda; H Lüllmann; T Peters
Journal:  Br J Pharmacol       Date:  1971-04       Impact factor: 8.739

View more
  5 in total

1.  Bilary and urinary excretion of five cardiac glycosides and its correlation with their physical and chemical properties.

Authors:  A Marzo; P Ghirardi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

2.  A simple approach to follow the metabolic degradation of cardiac glycosides in vivo.

Authors:  A Glover; F Kokenge; H Lüllmann; T Peters; K U Seiler; P A van Zweiten
Journal:  Klin Wochenschr       Date:  1971-10-01

3.  Hepatic clearance of gitoxin: pharmacokinetic study on rabbit isolated liver. Influence of protein binding and comparison with digoxin.

Authors:  P Pellegrin; M Lesne
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

4.  [A comparative study of the action of digoxigenin-mono, bis- and tridigitoxosides in the cat heart-lung preparation (author's transl)].

Authors:  H Böttcher; K Fischer; D Proppe
Journal:  Basic Res Cardiol       Date:  1975 May-Jun       Impact factor: 17.165

5.  Metabolism of cardiac glycosides studied in the isolated perfused guinea-pig liver.

Authors:  K D Kolenda; H Lüllmann; T Peters
Journal:  Br J Pharmacol       Date:  1971-04       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.